相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
4°C, sealed storage, away from moisture and light
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
18010-40-7
- 规格:
10 mM * 1 mL/100 mg/500 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥790.0 |
|---|---|---|---|
| 规格: | 100 mg | 产品价格: | ¥600.0 |
| 规格: | 500 mg | 产品价格: | ¥900.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Bupivacaine hydrochloride
CAS No. : 18010-40-7
MCE 国际站:Bupivacaine hydrochloride
产品活性:Bupivacaine hydrochloride 是一种 NMDA 受体抑制剂。Bupivacaine 可以阻断钠、L-钙和钾通道。Bupivacaine 有效阻断 SCN5A 通道,IC50 为 69.5 μM。Bupivacaine hydrochloride 可用于慢性疼痛的研究。
研究领域:Neuronal Signaling | Membrane Transporter/Ion Channel
作用靶点:iGluR | Sodium Channel | Calcium Channel | Potassium Channel
In Vitro: Bupivacaine hydrochloride inhibits NMDA receptor-mediated synaptic transmission in the dorsal horn of the spinal cord, an area critically involved in central sensitization.
?Bupivacaine hydrochloride influences the voltage dependency of channel activation and steady-state inactivation by shifting the membrane potential of half-maximal activation/inactivation toward somewhat more negative membrane potentials. In their inactivated state, SCN5A channels are slightly sensitive toward Bupivacaine hydrochloride IC50=2.18±0.16 μM.
?Bupivacaine hydrochloride reversibly inhibits the SK2 channel in a dose-dependent manner with the IC 50 of 16.5 μM.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Membrane Transporter/Ion Channel Compound Library | Neuronal Signaling Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Antiviral Compound Library | CNS-Penetrant Compound Library | Drug Repurposing Compound Library | NMPA-Approved Drug Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Anti-Alzheimer's Disease Compound Library | Neuroprotective Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Parkinson's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Rare Diseases Drug Library | Children’s Drug Library | Antidepressant Compound Library | EMA-Approved Drug Library | Calcium Channel Blocker Library | Sodium Channel Blocker Library | Potassium Channel Compound Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Anti-Prostate Cancer Compound Library | Non-steroidal Anti-Inflammatory Compound Library | Heterocyclic Compound Library | Off-patent Drug Library | Antihypertensive Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Ion Channel Compound Library | Nigericin sodium salt | Thapsigargin | Ionomycin | L-Ascorbic acid | Yoda 1 | BAPTA-AM | Corticosterone | Minocycline hydrochloride | Verapamil | 2-Aminoethyl diphenylborinate | Branaplam | Acetylcholine chloride | D-AP5 | Amiloride hydrochloride | Dizocilpine maleate | GSK1016790A | NMDA | L-Glutamic acid | Nifedipine | Fasudil Hydrochloride | Ebselen | Evans Blue | Rosuvastatin Calcium | CNQX | SCH-23390 hydrochloride | Kynurenic acid | Halofuginone | Glibenclamide
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验剂:200mg/10ml;400mg/20ml。浸润麻醉用0.25%~0.5%溶液,表面麻醉、传导麻醉、硬膜外麻醉均可用1%~2%溶液。一次极量500mg。腰麻不宜超过100mg。 盐酸布比卡因(bupivacaine hydrochloride)注射剂:12.5mg/5ml;25mg/5ml;37.5mg/5ml。浸润麻醉用0.25%溶液,传导麻醉用0.25%~0.5%溶液,硬膜外麻醉用0.5%~0.75%溶液。一次极量200mg,一日极量400mg。
。 盐酸丁卡因(tetracaine hydrochloride)注射剂:50mg/5ml。表面麻醉用0.25%~1%溶液,传导麻醉、腰麻及硬膜外麻醉可用0.2%溶液。腰麻不宜超过16mg。 盐酸利多卡因(lidocaine hydrochloride)注射剂:200mg/10ml;400mg/20ml。浸润麻醉用0.25%~0.5%溶液,表面麻醉、传导麻醉、硬膜外麻醉均可用1%~2%溶液。一次极量500mg。腰麻不宜超过100mg。 盐酸布比卡因(bupivacaine
Nick Translation of DNA for CGH
60 min 3 ul (16 comb) 100-2 kb PCR Amplified Microdissected DNA 40 ul mix 3.0 ul
技术资料暂无技术资料 索取技术资料

















